PRF Technologies Ltd. (PRFX) Stock Price, Financials & Summary

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.0x

Market Cap

$3.39M

MomentumView details →

1D Return

−1.14%

YTD Return

−70.11%

RSI (14)

41.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.0x

Market Cap

$3.39M

RSI (14)

41.9

MomentumView details →

1D Return

−1.14%

YTD Return

−70.11%

SummaryUpdated Dec 1, 2025

PainReform Ltd. (NASDAQ:PRFX) is a clinical-stage specialty pharmaceutical company founded in 2007 and based in Tel Aviv, Israel. The company went public in September 2020 and focuses on developing innovative pain management therapeutics specifically designed to provide extended post-surgical pain relief. PainReform is currently advancing its lead product candidate through late-stage clinical trials, positioning itself in the specialized field of localized post-operative pain management.

Ask drillr about PRF Technologies Ltd. →

ProfitabilityView details →

Gross Margin

−311.76%

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−98.50%

ROA (TTM)

−70.14%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+98.76%

FCF YoY

+45.18%

Revenue CAGR 3Y

−41.75%

EPS CAGR 3Y

+99.07%

EBITDA YoY

+48.78%

EarningsView details →

EPS (Actual)

−$9.60

EPS Surprise

—

Beats (12Q)

3/12

Next Q EPS Est

−$516.00

Avg Surprise (4Q)

−2106.73%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.78x

Quick Ratio

1.78x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

25500.00

Net Income (TTM)

−8.41M

Op. CF (TTM)

−6.92M

Latest newsMore news →

No recent news for PRFX.

Similar companies

Shuttle Pharmaceuticals Holdings, Inc.SHPH RedHill Biopharma Ltd.RDHL Sunshine Biopharma, Inc.SBFM Procaps Group, S.A.PROCW Akanda Corp.AKAN Sonoma Pharmaceuticals, Inc.SNOA Find similar companies →

Latest newsMore news →

No recent news for PRFX.